SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036232
Filing Date
2020-11-12
Accepted
2020-11-10 17:53:11
Documents
37
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_fsdevelopment.htm 10-Q 294360
2 CERTIFICATION f10q0920ex31-1_fsdevelopment.htm EX-31.1 14882
3 CERTIFICATION f10q0920ex31-2_fsdevelopment.htm EX-31.2 14775
4 CERTIFICATION f10q0920ex32-1_fsdevelopment.htm EX-32.1 5791
5 CERTIFICATION f10q0920ex32-2_fsdevelopment.htm EX-32.2 6170
  Complete submission text file 0001213900-20-036232.txt   1874942

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE fsdc-20200930.xml EX-101.INS 169022
7 XBRL SCHEMA FILE fsdc-20200930.xsd EX-101.SCH 27629
8 XBRL CALCULATION FILE fsdc-20200930_cal.xml EX-101.CAL 18872
9 XBRL DEFINITION FILE fsdc-20200930_def.xml EX-101.DEF 135724
10 XBRL LABEL FILE fsdc-20200930_lab.xml EX-101.LAB 235335
11 XBRL PRESENTATION FILE fsdc-20200930_pre.xml EX-101.PRE 141255
Mailing Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111
Business Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111 (415) 877-4887
FS Development Corp. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 201302377
SIC: 2834 Pharmaceutical Preparations